/
AIRS
$4.52-$0.05 (-1.09%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$322.4M
71M shares
52-week range
$1.51 – $12.00
29% from low
Sector
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change$-11.37
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $41.2M | $62.8M | $133.3M | $168.8M | $195.9M | $180.3M | $151.8M |
| Cost of revenue | $15.5M | $23.5M | $44.5M | $58.3M | $74.0M | $71.4M | $61.7M |
| Gross profit | $25.7M | $39.3M | $88.8M | $110.5M | $121.9M | $109.0M | $90.1M |
| Gross margin | 62.4% | 62.6% | 66.6% | 65.5% | 62.2% | 60.4% | 59.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $663.0K | $10.0M | $15.8M | −$4.5M | $9.5M | −$1.8M | −$4.8M |
| EBITDA | $5.6M | $15.7M | $22.4M | $4.6M | $19.7M | $10.1M | $1.2M |
| Net income | −$2.2M | $7.6M | $10.6M | −$14.7M | −$4.5M | −$8.3M | −$11.7M |
| Net margin | -5.4% | 12.1% | 7.9% | -8.7% | -2.3% | -4.6% | -7.7% |
| EPS (diluted) | -0.09 | 0.14 | -0.01 | -0.26 | -0.08 | -0.14 | -0.19 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $153M | $-0.04 | $-0.05–$-0.04 | 1 |
| 2027 | $157M | $-0.04 | $-0.04–$-0.03 | 1 |
| 2028 | $162M | $0.01 | $0.01–$0.01 | 2 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
AirSculpt Technologies, Inc. Common Stock
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
www.airsculpt.com- Employees
- 363
- IPO / List date
- Oct 29, 2021
- HQ
- MIAMI BEACH, FL
Held by traders on TradeandTell
No one on the platform currently holds AIRS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 1,005,464 | $2.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AIRS yet.
